FDA has approved the first ketamine-based antidepressant
Taken as a nasal spray, Spravato may quickly help people with hard-to-treat depression
KETAMINE’S SECOND LIFE A laboratory is churning out a newly approved antidepressant nasal spray that is based on ketamine, giving that powerful, old anesthetic new life as a treatment for severe depression.
Janssen Pharmaceuticals, Inc.